Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China

Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biotech has focused on developing T ...